课题基金 / 基金详情

RetroDecoys: Temporally-regulated and cell type selective technology for transcriptional control

RetroDecoys: Temporally-regulated and cell type selective technology for transcriptional control
RetroDecoys:用于转录控制的时间调节和细胞类型选择性技术
批准号:
10589891
负责人:
Seth Lawler Shipman
金额:
$28.35万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-03-15 至 2023-12-31

项目摘要

项目成果

Seth Lawler Shipman的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract Transcription factors orchestrate the most dynamic processes in cells – from producing cascades of antiviral and antibiotic resistance proteins to differentiation and metastasis. A change in the abundance of even a single transcription factor can induce a pattern of gene expression that fundamentally alters the transcriptome and physiology of a cell. Interestingly, the effect that a transcription factor has on gene expression is a function of both the abundance of the factor itself as well as the abundance of its binding site in DNA. As the number of DNA binding sites increases, the effect of each transcription factor molecule decreases. Yet, in cells, protein abundance changes and the number of DNA binding sites is static, so the transcription factor amount is the only point of dynamic control. We aim to engineer and test a molecular technology that will produce abundant transcription factor binding sites in DNA in vivo, on demand. These DNA molecules will compete for occupancy by the transcription factors, thereby antagonizing their action on endogenous genes. To build this technology, we will engineer retroelements to reverse transcribe the target site under the control of inducible and cell-type specific promoters. These elements can be integrated into genetic circuits as programmable parts for synthetic biology and a means to exert control over a transcriptome that is responsive to a cell's state. They also enable antagonism of transcription factors that currently have no small molecule antagonist. We will validate this approach in two clinically relevant models: cancer progression and antibiotic resistance.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
RetroDecoys: Temporally-regulated and cell type selective technology for transcriptional control
  • 批准号:
    10373249
  • 项目类别:
  • 资助金额:
    $23.63万
  • 财政年份:
    2022
  • 负责人:
    Seth Lawler Shipman
  • 依托单位:
Engineered Mitochondria for Therapeutic Donation and Mitochondrial Genome Editing
  • 批准号:
    10001252
  • 项目类别:
  • 资助金额:
    $283.5万
  • 财政年份:
    2020
  • 负责人:
    Seth Lawler Shipman
  • 依托单位:
海外基金